Search
for
Sort by
Research 31–60 of 304
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Editor’s Picks June 2025
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Baricitinib for the Treatment of Alopecia Areata
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Ritlecitinib: First Approval
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Exploration of Natural Adsorbents for Applications in Pollution-Reducing Cosmetic Formulations
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata